NDANASALSPRAY, METERED
Approved
May 2012
Lifecycle
Post-LOE
Competitive Pressure
35/100
Clinical Trials
5
Data completeness
6/8 — Strong
DYMISTA (azelastine hydrochloride and fluticasone propionate) by Viatris is propionate; therefore, the mechanisms of actions described below for the individual components apply to dymista. First approved in 2012.
Drug data last refreshed 13h ago · AI intelligence enriched Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
DYMISTA is a fixed-dose combination nasal spray combining azelastine hydrochloride (H1-receptor antagonist) and fluticasone propionate (synthetic corticosteroid) for allergic rhinitis. The dual mechanism addresses both histamine-mediated symptoms and underlying inflammation through complementary pathways. It represents a convenient single-product approach to multi-mechanism allergic rhinitis management.
$0.487MPart D
Post-LOEDeclining
Post-LOEProduct is in post-LOE phase with modest Part D utilization; brand teams should focus on defensive strategies and lifecycle extension rather than growth initiatives.
Mechanism of Action
propionate; therefore, the mechanisms of actions described below for the individual components apply to DYMISTA. These drugs represent two different classes of medications (histamine H 1 -receptor antagonist and synthetic corticosteroid). Azelastine Hydrochloride Azelastine hydrochloride, a…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Worked on DYMISTA at Viatris? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.